Ron Neumann, Co-chair at ISOPT, introduces the 14th ISOPT Clinical meeting in Tel Aviv, Israel. This year's meeting focussed on the latest innovations in drug and device therapies that are being introduced to ophthalmologists that are changing clinical practice.
As well as peer-reviewed journals touchOPHTHALMOLOGY also provide video interviews, procedures and general updates on the latest trends within the area, as well as featuring carefully selected video from our partners.
Rolando and Melissa Toyos talk about their current research into intense pulse light (IPL) therapy for dry eye disease. IPL therapy is a light treatment applied to the skin to stimulate the meibomian glands to produce a better tear. The current study looks at the efficacy of IPL versus meibomian...
Rolando & Melissa Toyos discuss the ongoing healthcare challenges in the US and how they hope to make a difference. Keywords: Innovation, clinical, US healthcare, patient needs, ophthalmologists, Rand Paul, US Senator, healthcare spending, Medicaid, insurance, foreign policy
Francine Behar-Cohen discusses the treatment needs in CNV including effective anti-angiogenic drugs to inhibit the growth and survival of the neovessels and effective control of the scarring process. The introduction of OCT-A has proven useful in the identification of CNV but the real challenge is...
Joseph Tauber, Tauber Eye Center, discusses the complexity of dry eye disease (DED) and potential causes. Whilst there are several treatment strategies available for DED there is still an unmet need for patient satisfaction. Lifitegrast is an LFA-1 inhibitor and the first drug to improve both the...
Baruch Kuppermann discusses the challenges of treating patients with dry AMD. Unlike wet AMD, which is responsive to anti-VEGF therapy, there are multiple challenges with wet AMD including the complement pathway and neuroprotection. There is an ongoing search into new ways of tracking wet AMD to...
Jay Pepose, Washington Univeristy School of Medicine, talks about his recent study of topical lifitegrast in patients with dry eye disease. The aim of the study was to determine if tear osmolarity might be a leading indicator of patient response to lifitegrast, and whether this could be used to...
Penny Asbell discusses the role of inflammation in DED and the advantages and limitations of HLA-DR as a biomarker.
Baruch Kuppermann discusses integrin peptide therapy and where it may fit within the current treatment regimen for patients with DME.
Irina Barequet talks about her research into corneal crosslinking in bacterial keratitis and enzyme therapy for ocular infections.
Francesco Boscia shares his thoughts on selecting the appropriate intravitreal anti-VEGF therapy and approach to patients who are not responding to treatment.
Asaf Achiron talks about his recent clinical trial investigating the effects of lifestyle changes on IOP and illness perception in patients with glaucoma.
Dr Ike Ahmed demonstrates needling a failed XEN. Read more about gel stent implantation in the recent article published in US Ophthalmic Review HERE. Keywords: Glaucoma, microinvasive glaucoma surgery (MIGS), gel stent, gel implant
Dr Ahmed demonstrates repositioning in gel stent implantation. Read more about gel stent implantation in the recent article published in US Ophthalmic Review HERE. Keywords: Glaucoma, microinvasive glaucoma surgery (MIGS), gel stent, gel implant
Dr Reitsamer demonstrates primary needling. Read more about gel stent implantation in the recent article published in US Ophthalmic Review HERE. Keywords: Glaucoma, microinvasive glaucoma surgery (MIGS), gel stent, gel implant